Kutzkey Tim — SEC insider filings
SEC reporting owner CIK 1614186. 61 insider filings on record with FilingPulse; latest filed 2026-10-22.
Transaction summary — filings shown
Covers the 50 most recent of 61 filings on record, filed 2021-08-24 to 2026-10-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 96 legs across 34 filings — 7,980,194 shares, $92,427,300 total (shares × price as filed on priced legs).
- Open-market sales (code S, non-derivative): 58 legs across 8 filings — 9,791,391 shares, $19,653,423 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 67.
- Largest priced transaction: purchase of 1,437,323 shares @ $18.00 ($25,871,814) in Eikon Therapeutics, Inc., filed 2026-02-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Eikon Therapeutics, Inc. (EIKN) | 10% owner | 2 | 4 legs · 2,206,960 sh · $39,150,725 | — | 14 |
| NGM BIOPHARMACEUTICALS INC (NGM) | 10% owner | 23 | 62 legs · 3,690,481 sh · $27,605,175 | — | 14 |
| RAPT Therapeutics, Inc. (RAPT) | 10% owner | 9 | 8 legs · 1,278,450 sh · $13,686,784 | 46 legs · 391,101 sh · $13,726,224 | 17 |
| Surrozen, Inc./DE (SRZN) | Director, 10% owner | 13 | 22 legs · 804,303 sh · $11,984,616 | — | 22 |
| Tenaya Therapeutics, Inc. (TNYA) | 10% owner | 3 | — | 12 legs · 9,400,290 sh · $5,927,199 | — |
Insider filings — Kutzkey Tim
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-22 | 4 | Surrozen, Inc./DE (SRZN) | Option exercise/expiry (X): 485,830 @ $11.60 · Option exercise/expiry (X): 548,653 @ $11.60 · Option exercise/expiry (X): 517,241 @ $11.60 · Option exercise/expiry (X): 728,745 (derivative) · Option exercise/expiry (X): 822,980 (derivative) · Option exercise/expiry (X): 775,861 (derivative) · +3 more | EDGAR |
| 2026-09-08 | 4 | Eikon Therapeutics, Inc. (EIKN) jointly with Column Group IV GP, LP, Column Group IV-A, LP, Column Group IV, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Svennilson Peter | Purchase (P): 89,200 @ $11.56 | EDGAR |
| 2026-05-19 | 4 | Surrozen, Inc./DE (SRZN) | Grant/award (A): 5,550 (derivative) @ $0 | EDGAR |
| 2026-02-26 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Svennilson Peter | Sale (S): 309,228 @ $0.62 · Sale (S): 349,212 @ $0.62 · Sale (S): 1,649,281 @ $0.56 · Sale (S): 1,862,545 @ $0.56 | EDGAR |
| 2026-02-24 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Svennilson Peter | Sale (S): 245,965 @ $0.61 · Sale (S): 277,769 @ $0.61 · Sale (S): 143,709 @ $0.60 · Sale (S): 162,291 @ $0.60 | EDGAR |
| 2026-02-12 | 4 | Tenaya Therapeutics, Inc. (TNYA) jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Svennilson Peter | Sale (S): 161,422 @ $0.82 · Sale (S): 182,295 @ $0.82 · Sale (S): 1,905,115 @ $0.68 · Sale (S): 2,151,458 @ $0.68 | EDGAR |
| 2026-02-09 | 4 | Eikon Therapeutics, Inc. (EIKN) jointly with Column Group IV GP, LP, Column Group IV-A, LP, Column Group IV, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Svennilson Peter | Conversion (C): 1,296,629 · Conversion (C): 1,403,568 · Conversion (C): 110,928 · Conversion (C): 44,249 · Conversion (C): 47,898 · Conversion (C): 3,785 · +11 more | EDGAR |
| 2026-01-20 | 4 | Surrozen, Inc./DE (SRZN) | Purchase (P): 5,590 @ $19.89 · Purchase (P): 6,303 @ $19.89 · Purchase (P): 1,204 @ $20 · Purchase (P): 1,358 @ $20 · Purchase (P): 8,484 @ $19.60 · Purchase (P): 9,568 @ $19.60 | EDGAR |
| 2026-01-15 | 4 | Surrozen, Inc./DE (SRZN) | Purchase (P): 5,861 @ $19.80 · Purchase (P): 6,609 @ $19.80 · Purchase (P): 2,596 @ $19.99 · Purchase (P): 2,927 @ $19.99 | EDGAR |
| 2026-01-08 | 4 | Surrozen, Inc./DE (SRZN) | Purchase (P): 7,097 @ $19.89 · Purchase (P): 8,003 @ $19.89 | EDGAR |
| 2025-12-08 | 4 | Surrozen, Inc./DE (SRZN) | Purchase (P): 2,475 @ $17.35 · Purchase (P): 14,503 @ $19.54 · Purchase (P): 2,791 @ $17.35 · Purchase (P): 16,381 @ $19.54 | EDGAR |
| 2025-12-02 | 4 | Surrozen, Inc./DE (SRZN) | Purchase (P): 148,150 @ $12.65 · Purchase (P): 167,307 @ $12.65 | EDGAR |
| 2025-03-28 | 4 | Surrozen, Inc./DE (SRZN) | Grant/award (A): 2,666 (derivative) @ $0 | EDGAR |
| 2024-12-23 | 4 | RAPT Therapeutics, Inc. (RAPT) jointly with COLUMN GROUP II, LP, Column Group II GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, GOEDDEL DAVID V, Svennilson Peter, Column Group LLC | Other (J): 1,352,008 · Other (J): 1,599,417 · Other (J): 1,352,008 (derivative) · Other (J): 1,599,417 (derivative) | EDGAR |
| 2024-06-06 | 4 | Surrozen, Inc./DE (SRZN) | Grant/award (A): 1,333 (derivative) @ $0 | EDGAR |
| 2024-04-17 | 4/A | Surrozen, Inc./DE (SRZN) | Purchase (P): 90,897 @ $15.50 · Purchase (P): 102,651 @ $15.50 | EDGAR |
| 2024-04-08 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, Svennilson Peter, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP | Disposition to issuer (D): 949,862 · Disposition to issuer (D): 2,650,177 · Disposition to issuer (D): 90,442 · Disposition to issuer (D): 11,103,333 · Disposition to issuer (D): 858,035 · Disposition to issuer (D): 968,990 · +8 more | EDGAR |
| 2024-04-08 | 4 | Surrozen, Inc./DE (SRZN) | Purchase (P): 90,897 @ $15.50 · Purchase (P): 102,651 @ $15.50 · Purchase (P): 90,897 (derivative) · Purchase (P): 102,651 (derivative) · Purchase (P): 98,870 (derivative) · Purchase (P): 111,656 (derivative) · +4 more | EDGAR |
| 2023-11-17 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, Svennilson Peter, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP | Purchase (P): 16,791 @ $0.71 · Purchase (P): 5,840 @ $0.62 | EDGAR |
| 2023-05-19 | 4 | Surrozen, Inc./DE (SRZN) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-02-01 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, Svennilson Peter, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP | Purchase (P): 7,542 @ $5.00 · Purchase (P): 176,730 @ $5.00 | EDGAR |
| 2023-01-25 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, Svennilson Peter, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP | Purchase (P): 9,900 @ $5.00 | EDGAR |
| 2023-01-23 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, Svennilson Peter, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP | Purchase (P): 37,639 @ $5.00 · Purchase (P): 500 @ $5.00 | EDGAR |
| 2023-01-17 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, Svennilson Peter, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP | Purchase (P): 5,378 @ $4.95 | EDGAR |
| 2023-01-12 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, Svennilson Peter, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP | Purchase (P): 100,070 @ $4.84 · Purchase (P): 209,000 @ $4.76 | EDGAR |
| 2022-12-14 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, Svennilson Peter, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP | Purchase (P): 300 @ $4.98 | EDGAR |
| 2022-11-23 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, Svennilson Peter, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP | Purchase (P): 35,997 @ $5.00 · Purchase (P): 4,330 @ $5.00 | EDGAR |
| 2022-11-07 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, Svennilson Peter, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP | Purchase (P): 104,090 @ $4.99 · Purchase (P): 35,058 @ $4.72 | EDGAR |
| 2022-10-31 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, Svennilson Peter, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP | Purchase (P): 76,877 @ $4.86 | EDGAR |
| 2022-10-27 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, Svennilson Peter, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP | Purchase (P): 51,046 @ $4.75 · Purchase (P): 72,774 @ $4.85 | EDGAR |
| 2022-06-13 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, Svennilson Peter, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP | Purchase (P): 951,684 @ $13.50 · Purchase (P): 32,477 @ $13.50 | EDGAR |
| 2022-06-09 | 4 | Surrozen, Inc./DE (SRZN) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2022-06-06 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, Svennilson Peter, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP | Purchase (P): 33,071 @ $13.03 · Purchase (P): 1,129 @ $13.03 | EDGAR |
| 2022-06-02 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, Svennilson Peter, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP | Purchase (P): 59,766 @ $13.47 · Purchase (P): 2,040 @ $13.47 · Purchase (P): 88,964 @ $13.45 · Purchase (P): 3,036 @ $13.45 | EDGAR |
| 2022-05-31 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, Svennilson Peter, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP | Purchase (P): 19,534 @ $13.49 · Purchase (P): 667 @ $13.49 · Purchase (P): 2,621 @ $13.45 · Purchase (P): 89 @ $13.45 | EDGAR |
| 2022-05-27 | 4 | RAPT Therapeutics, Inc. (RAPT) jointly with COLUMN GROUP II, LP, Column Group II GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, GOEDDEL DAVID V, Svennilson Peter, Column Group LLC | Purchase (P): 1,837 @ $12.45 · Purchase (P): 63 @ $12.45 | EDGAR |
| 2022-05-26 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, Svennilson Peter, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP | Purchase (P): 17,240 @ $13.37 · Purchase (P): 588 @ $13.37 · Purchase (P): 41,863 @ $13.43 · Purchase (P): 1,429 @ $13.43 | EDGAR |
| 2022-05-25 | 4 | RAPT Therapeutics, Inc. (RAPT) jointly with COLUMN GROUP II, LP, Column Group II GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, GOEDDEL DAVID V, Svennilson Peter, Column Group LLC | Purchase (P): 9,898 @ $12.50 · Purchase (P): 338 @ $12.50 · Purchase (P): 15,776 @ $12.00 · Purchase (P): 538 @ $12.00 | EDGAR |
| 2022-05-23 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, Svennilson Peter, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP | Purchase (P): 19,984 @ $13.25 · Purchase (P): 682 @ $13.25 · Purchase (P): 18,406 @ $13.48 · Purchase (P): 628 @ $13.48 | EDGAR |
| 2022-05-19 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, Svennilson Peter, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP | Purchase (P): 86,110 @ $13.42 · Purchase (P): 2,939 @ $13.42 · Purchase (P): 60,583 @ $13.20 · Purchase (P): 2,067 @ $13.20 | EDGAR |
| 2022-05-17 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, Svennilson Peter, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP | Purchase (P): 125,096 · Purchase (P): 4,269 · Purchase (P): 32,072 @ $12.90 · Purchase (P): 1,094 @ $12.90 | EDGAR |
| 2022-05-13 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, Svennilson Peter, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP | Purchase (P): 77,866 @ $11.23 · Purchase (P): 2,657 @ $11.23 · Purchase (P): 2,564 @ $11.85 · Purchase (P): 88 @ $11.85 · Purchase (P): 79,945 @ $11.62 · Purchase (P): 2,728 @ $11.62 · +2 more | EDGAR |
| 2022-05-12 | 4 | RAPT Therapeutics, Inc. (RAPT) jointly with COLUMN GROUP II, LP, Column Group II GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, GOEDDEL DAVID V, Svennilson Peter, Column Group LLC | Purchase (P): 1,208,750 @ $10.67 · Purchase (P): 41,250 @ $10.67 | EDGAR |
| 2022-05-11 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, Svennilson Peter, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP | Purchase (P): 80,430 @ $10.79 · Purchase (P): 2,745 @ $10.79 · Purchase (P): 30,233 @ $11.36 · Purchase (P): 1,032 @ $11.36 | EDGAR |
| 2022-01-26 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, Svennilson Peter, Ponoi Capital II, LP, Ponoi II Management, LLC, PONOI CAPITAL, LP, Ponoi Management, LLC, COLUMN GROUP II, LP, Column Group Management LP, Column Group II GP, LP | Purchase (P): 241,750 · Purchase (P): 8,250 · Purchase (P): 579,910 · Purchase (P): 19,791 | EDGAR |
| 2021-09-29 | 4 | RAPT Therapeutics, Inc. (RAPT) jointly with COLUMN GROUP II, LP, Column Group II GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, GOEDDEL DAVID V, Svennilson Peter, Column Group LLC | Option exercise (M): 7,500 @ $28.27 · Sale (S): 7,500 @ $34.48 · Option exercise (M): 1,114 @ $22.20 · Sale (S): 1,114 @ $34.97 · Option exercise (M): 625 @ $19.30 · Sale (S): 625 @ $34.94 · +3 more | EDGAR |
| 2021-09-16 | 4 | RAPT Therapeutics, Inc. (RAPT) jointly with COLUMN GROUP II, LP, Column Group II GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, GOEDDEL DAVID V, Svennilson Peter, Column Group LLC | Sale (S): 1,400 @ $35.71 · Sale (S): 29,634 @ $36.79 · Sale (S): 25,351 @ $37.27 · Sale (S): 1,700 @ $35.77 · Sale (S): 42,151 @ $36.92 · Sale (S): 10,807 @ $37.31 · +7 more | EDGAR |
| 2021-09-14 | 4 | RAPT Therapeutics, Inc. (RAPT) jointly with COLUMN GROUP II, LP, Column Group II GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, GOEDDEL DAVID V, Svennilson Peter, Column Group LLC | Other (J): 1,166,666 @ $0 · Other (J): 279,710 @ $0 · Other (J): 279,710 @ $0 · Other (J): 72 @ $0 · Other (J): 84,307 @ $0 · Other (J): 84,307 @ $0 · +7 more | EDGAR |
| 2021-09-03 | 4 | RAPT Therapeutics, Inc. (RAPT) jointly with COLUMN GROUP II, LP, Column Group II GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, GOEDDEL DAVID V, Svennilson Peter, Column Group LLC | Sale (S): 6,904 @ $35.02 · Sale (S): 8,976 @ $35.39 · Sale (S): 8,805 @ $35.06 · Sale (S): 7,064 @ $35.46 · Sale (S): 18,545 @ $35.43 · Sale (S): 18,556 @ $35.43 | EDGAR |
| 2021-08-24 | 4 | RAPT Therapeutics, Inc. (RAPT) jointly with COLUMN GROUP II, LP, Column Group II GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, GOEDDEL DAVID V, Svennilson Peter, Column Group LLC | Sale (S): 1,440 @ $30.09 · Sale (S): 1,429 @ $30.08 · Sale (S): 1,670 @ $30.07 · Sale (S): 7,605 @ $30.93 · Sale (S): 12,969 @ $31.41 · Sale (S): 2,200 @ $32.35 · +12 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1614186 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs